Organogenesis Holdings (ORGO) Preferred Dividend Payments (2024 - 2026)
Organogenesis Holdings' (ORGO) quarterly Preferred Dividend Payments came in at $2.8 million in Q1 2026, up 2250.41% year-on-year from $121000.0 in Q1 2025, and up 1796.0% quarter-over-quarter from $150000.0 in Q4 2025.
Organogenesis Holdings (ORGO) Preferred Dividend Payments (2024 - 2026) Analysis & Trends
Organogenesis Holdings' Preferred Dividend Payments history runs 3 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- On a quarterly basis, Preferred Dividend Payments rose 2250.41% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $5.9 million, a 1015.2% increase from a year earlier, with the FY2025 full-year figure at $540000.0, up 31.07% from the prior year.
- Preferred Dividend Payments rose to $2.8 million in Q1 2026 per ORGO's latest filing, from $150000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.8 million in Q1 2026 and bottomed at $121000.0 in Q1 2025.
- The 3-year median for Preferred Dividend Payments is $281000.0 (2024), against an average of $1.1 million.
- Across the five-year window, Preferred Dividend Payments slumped 63.59% in 2025 and jumped 2250.41% in 2026, its largest moves.
- Year by year, Preferred Dividend Payments stood at $412000.0 in 2024, then plunged by 63.59% to $150000.0 in 2025, then surged by 1796.0% to $2.8 million in 2026.
- Per Business Quant, the three latest ORGO Preferred Dividend Payments figures stand at $2.8 million (Q1 2026), $150000.0 (Q4 2025), and $140000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 150,000.00 |
| Sep 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 412,000.00 |